Home > National Drug Code (NDC) > Glycopyrrolate

Glycopyrrolate - 10019-016-54 - (Glycopyrrolate)

Alphabetical Index


Drug Information of Glycopyrrolate

Product NDC: 10019-016
Proprietary Name: Glycopyrrolate
Non Proprietary Name: Glycopyrrolate
Active Ingredient(s): .2    mg/mL & nbsp;   Glycopyrrolate
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Glycopyrrolate

Product NDC: 10019-016
Labeler Name: Baxter Healthcare Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA017558
Marketing Category: NDA
Start Marketing Date: 20101217

Package Information of Glycopyrrolate

Package NDC: 10019-016-54
Package Description: 25 VIAL, MULTI-DOSE in 1 PACKAGE (10019-016-54) > 5 mL in 1 VIAL, MULTI-DOSE (10019-016-36)

NDC Information of Glycopyrrolate

NDC Code 10019-016-54
Proprietary Name Glycopyrrolate
Package Description 25 VIAL, MULTI-DOSE in 1 PACKAGE (10019-016-54) > 5 mL in 1 VIAL, MULTI-DOSE (10019-016-36)
Product NDC 10019-016
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Glycopyrrolate
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20101217
Marketing Category Name NDA
Labeler Name Baxter Healthcare Corporation
Substance Name GLYCOPYRROLATE
Strength Number .2
Strength Unit mg/mL
Pharmaceutical Classes

Complete Information of Glycopyrrolate


General Information